Regional research funding to Lorena Arranz: 9 million NOK to the NEUROTARGET project
Lorena Arranz, leader of the Stem Cells, Ageing and Cancer research group at the Department of Microbiology and Deputy Centre Director of CRESCO, has received 9 million NOK in funding from Helse Sør-Øst RHF for her project NEUROTARGET: The nervous system as a druggable vulnerability in myeloid blood cancers.
Regional research funding for 2026
Helse Sør-Øst RHF has awarded regional research funding to 96 research projects starting in 2026. The projects cover a wide range of disciplines and aim to contribute new knowledge and improved patient care. Lorena Arranz received funding from the thematic open structure, available to all research areas in the specialist healthcare services.
Exploring a nervous-system polymorphism in myeloid blood cancers
Arranz’ group have identified a polymorphism related to the nervous system function, which is enriched in patients of myelodysplastic syndromes, acute myeloid leukemia and myeloproliferative neoplasms. The team will now characterize its pathogenic potential in vivo and the value of its targeting as therapy in preclinical models. The aim of NEUROTARGET is to provide the scope for a larger project with expected benefit for future care of patients with myeloid cancers.
Photo: Åsne Rambøl Hillestad, UiO
Links:
The Stem Cells, Ageing and Cancer research group, headed by Lorena Arranz
CRESCOs website: www.cresco.uio.no